The yield of tuberculosis contact investigation in low- and middle-income settings: a systematic review and meta-analysis.

Contact investigation Mycobacterium tuberculosis Systematic Review Tuberculosis

Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
27 Sep 2021
Historique:
received: 26 02 2021
accepted: 17 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 30 9 2021
Statut: epublish

Résumé

Contact investigation, the systematic evaluation of individuals in close contact with an infectious tuberculosis (TB) patient, is a key active case-finding strategy for global TB control. Better estimates of the yield of contact investigation can guide strategies to reduce the number of underreported and underdiagnosed TB cases, approximately three million cases per year globally. A systematic review (Prospero ID # CRD42019133380) and meta-analysis was conducted to update and enhance the estimates of the yield of TB contact investigation in low- and middle-income countries (LMIC). Pubmed, Web of Science, Embase and the WHO Global Index Medicus were searched for peer-reviewed studies (published between January 2006-April 2019); studies reporting the number of active TB or latent tuberculosis infection (LTBI) found through contact investigation were included. Pooled data were meta-analyzed using a random effects model and risk of bias was assessed. Of 1,644 unique citations obtained from database searches, 110 studies met eligibility criteria for descriptive data synthesis and 95 for meta-analysis. The pooled yields of contact investigation activities for different outcomes were: secondary cases of all active TB (defined as those bacteriologically confirmed or clinically diagnosed) 2.87% (2.61-3.14, I This study provides methodologically rigorous and up-to-date estimates for the yield of TB contact investigation activities in low- and middle-income countries (LMIC). While the data are heterogenous, these findings can inform strategic and programmatic planning for scale up of TB contact investigation activities.

Sections du résumé

BACKGROUND BACKGROUND
Contact investigation, the systematic evaluation of individuals in close contact with an infectious tuberculosis (TB) patient, is a key active case-finding strategy for global TB control. Better estimates of the yield of contact investigation can guide strategies to reduce the number of underreported and underdiagnosed TB cases, approximately three million cases per year globally. A systematic review (Prospero ID # CRD42019133380) and meta-analysis was conducted to update and enhance the estimates of the yield of TB contact investigation in low- and middle-income countries (LMIC). Pubmed, Web of Science, Embase and the WHO Global Index Medicus were searched for peer-reviewed studies (published between January 2006-April 2019); studies reporting the number of active TB or latent tuberculosis infection (LTBI) found through contact investigation were included. Pooled data were meta-analyzed using a random effects model and risk of bias was assessed.
RESULTS RESULTS
Of 1,644 unique citations obtained from database searches, 110 studies met eligibility criteria for descriptive data synthesis and 95 for meta-analysis. The pooled yields of contact investigation activities for different outcomes were: secondary cases of all active TB (defined as those bacteriologically confirmed or clinically diagnosed) 2.87% (2.61-3.14, I
CONCLUSIONS CONCLUSIONS
This study provides methodologically rigorous and up-to-date estimates for the yield of TB contact investigation activities in low- and middle-income countries (LMIC). While the data are heterogenous, these findings can inform strategic and programmatic planning for scale up of TB contact investigation activities.

Identifiants

pubmed: 34579667
doi: 10.1186/s12879-021-06609-3
pii: 10.1186/s12879-021-06609-3
pmc: PMC8474777
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1011

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2021. The Author(s).

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
N Engl J Med. 2018 Jan 18;378(3):221-229
pubmed: 29342390
PLoS One. 2016 Mar 01;11(3):e0150405
pubmed: 26930415
Am J Respir Crit Care Med. 2014 Apr 1;189(7):845-52
pubmed: 24559425
Implement Sci. 2017 Mar 9;12(1):33
pubmed: 28274245
PLoS One. 2016 Sep 01;11(9):e0162090
pubmed: 27583974
Lancet Infect Dis. 2008 Jun;8(6):359-68
pubmed: 18450516
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
Lancet. 2016 Mar 19;387(10024):1211-26
pubmed: 26377143
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Am J Public Health. 2011 Apr;101(4):654-62
pubmed: 21330583
Infect Dis Rep. 2016 Jun 24;8(2):6570
pubmed: 27403269
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):935-940
pubmed: 28786803
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Lancet Glob Health. 2018 Dec;6(12):e1260-e1261
pubmed: 30266569
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
J Clin Epidemiol. 2014 Aug;67(8):897-903
pubmed: 24794697
Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1048-55
pubmed: 15968029
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Int J Tuberc Lung Dis. 2015 Mar;19(3):269-72
pubmed: 25686131
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710

Auteurs

Mariana Velleca (M)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA, USA.

Mohsen Malekinejad (M)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.

Cecily Miller (C)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.
Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Lucia Abascal Miguel (L)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.

Hailey Reeves (H)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.

Philip Hopewell (P)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA, USA.

Elizabeth Fair (E)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA, USA. elizabeth.fair@ucsf.edu.
Institute for Global Health Sciences, University of California, San Francisco, CA, USA. elizabeth.fair@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH